Aladin activators constitute a specialized class of chemical compounds known for their ability to modulate the activity of the Aladin protein, also known as Adracalin or AAAS (Achalasia-Addisonianism-Alacrima Syndrome protein). Aladin is an essential component of the nuclear pore complex (NPC), a crucial structure that regulates the transport of macromolecules between the nucleus and the cytoplasm in eukaryotic cells. These activators are meticulously designed to interact with Aladin, potentially influencing its functions and affecting the integrity and functionality of the NPC. At the molecular level, the mechanisms through which Aladin activators exert their effects can be complex, often involving binding to specific regions of the protein or modulating its interactions with other nucleoporins and transport factors.
Research on Aladin activators is fundamental for advancing our understanding of nuclear transport and the intricate mechanisms that control the movement of molecules in and out of the nucleus, which is essential for gene expression and cellular function. Scientists in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact Aladin's function and their downstream effects on nucleocytoplasmic transport. Aladin is an important component of the NPC, and its dysfunction can lead to severe genetic disorders, making it a critical protein for studying nuclear transport-related diseases. Moreover, these compounds serve as valuable tools for researchers seeking to investigate the molecular basis of nucleocytoplasmic transport and its implications in various cellular processes, ultimately deepening our understanding of cellular biology and the regulation of gene expression.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Modifie la différenciation cellulaire et pourrait influencer l'expression des protéines du complexe du pore nucléaire. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Modulateur épigénétique; pourrait potentiellement avoir un impact indirect sur l'expression de l'Aladin via la déméthylation de l'ADN. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibiteur de l'histone désacétylase; pourrait moduler l'expression de l'Aladin par des modifications de l'accessibilité de la chromatine. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Inhibiteur du protéasome; pourrait affecter indirectement la stabilité ou l'expression d'Aladin. | ||||||
Chloroquine Sulphate | 132-73-0 | sc-337629 | 25 mg | $224.00 | 2 | |
Affecte l'acidification des endosomes et pourrait influencer indirectement le transport nucléaire-cytoplasmique. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibiteur de l'ARN polymérase II; pourrait influencer indirectement Aladin en raison de son rôle dans la synthèse de l'ARNm. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Perturbe les microtubules; pourrait influencer le transport nucléaire et potentiellement Aladin. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibiteur de la synthèse des protéines; pourrait avoir un impact indirect sur l'expression de l'Aladin par le biais d'effets cellulaires plus larges. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Inhibiteur de l'ADN topoisomérase; pourrait influencer indirectement l'Aladin via les voies de réponse aux dommages de l'ADN. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibiteur de l'ADN topoisomérase I; pourrait influencer indirectement l'expression de l'aladin en raison de la réponse cellulaire aux lésions de l'ADN. | ||||||